mail
versión imprimible
 
 

Next Generation Cardiovascular Drug Development Summit

Evvnt Promotion / evvnt
-
25.04.2023 - 27.04.2023  Hyatt Regency Boston, One Ave. de Lafayette, 02111 Boston, Massachusetts, USA
Time: 9:00 am - 4:00 pm
 
Temas de la conferencia
Are you up to date on the latest research and developments in novel biologics to enhance regenerative and precision cardiovascular therapeutics?

Don't miss the Next Generation Cardiovascular Drug Development Summit, coming to Boston on April 25-27 as the only industry-focused meeting dedicated to leveraging novel cell and gene therapies using mRNA, CRISPR/Cas9 and iPSCs for cardiovascular disease.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/1492007-0?pid=4832

Speakers: Christopher O'Donnell, Global Head Cardiovascular and Metabolism Translational Medicine, Novartis Institutes of Biomedical Research, and more.
 

Información e inscripción:

https://go.evvnt.com/1492007-1?pid=4832
Ms. Nina Podmore
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developer - Conference Only: USD 2999.00, Academic and Research - Conference Only: USD 2599.00, Solution Provider - Conference Only: USD 3799.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltAGEM - Arbeitsgemeinschaft Ethnologie und MedizinnewTreeEuropean Health Forum GasteinAnästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteÖsterreichische Akademie der Ärzte